XENE Q4 2019 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-44.5% YoY

Gross Profit

$3M100.0% margin

Operating Income

-$12M-348.4% margin

Net Income

-$11M-341.7% margin

EPS (Diluted)

$0.00

QoQ Revenue Growth

-4.9%

Cash Flow

Operating Cash Flow

$20M

Free Cash Flow

$19M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$148M

Total Liabilities

$56M

Stockholders' Equity

$92M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$6M	-44.5%
Gross Profit	$3M	-$402,000	+928.1%
Operating Income	-$12M	-$8M	-37.5%
Net Income	-$11M	-$9M	-32.9%